Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trialDavid E. Kandzari, Denise Reedus, Khaled M. Ziada et al.|The Lancet|2018Cited by 775
Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trialMichael Böhm, Benjamin Blossom, Joachim Weil et al.|The Lancet|2020Cited by 586
Predictors of blood pressure response in the SYMPLICITY HTN-3 trialDavid E. Kandzari, George L. Bakris, Martin Fahy et al.|European Heart Journal|2014Cited by 540
Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trialFelix Mahfoud, Michael Böhm, Kazuomi Kario et al.|The Lancet|2022Cited by 282
Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive MedicationsDavid E. Kandzari, Bruno Farah, Lucas Lauder et al.|Journal of the American College of Cardiology|2023Cited by 115